about
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the ful...
Read More
12.10
-0.18
(-1.47%)
197.7K
XNAS Volume
XNAS 29 Aug, 2025 4:10 PM (EDT)
Board Meeting
The board meeting for Septerna Inc. is scheduled for today, for the purpose of Septerna Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Septerna Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..